Guaifenesin Patent Expiration
Guaifenesin is Used for treating respiratory conditions by promoting the expulsion of mucus from the lungs. It was first introduced by Rb Health Us Llc
Guaifenesin Patents
Given below is the list of patents protecting Guaifenesin, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Mucinex | US6372252 | Guaifenesin sustained release formulation and tablets |
Apr 28, 2020
(Expired) | Rb Hlth |
| Mucinex | US6955821 | Sustained release formulations of guaifenesin and additional drug ingredients |
Apr 28, 2020
(Expired) | Rb Hlth |
| Mucinex | US7838032 | Sustained release of guaifenesin |
Apr 28, 2020
(Expired) | Rb Hlth |
About Veterinary Guaifenesin
Guaifenesin is used in drugs marketed by 3 different companies: Summit Hill Laboratories, Zoetis Inc, Elanco Us Inc.
Other drugs containing Guaifenesin are: Gecolate, glycodex injection , Guailaxin , Guaifenesin injection , Gecolate
Guaifenesin's Family Patents
